Cystic fibrosis gene therapy, what is it? CF gene therapy is the use of viruses or adeno-associated viruses (AAV) to transfer the CFTR gene into the airway cells of cystic fibrosis patients. CFTR is a protein necessary for the epithelial cells in the respiratory tract to allow ions to transport, which is essential for maintaining normal lung function. When the gene mutates, it cannot produce enough protein and causes the disease. That’s what cystic fibrosis gene therapy is about more or less.
Scientists identified the CFTR gene
After scientists identified the CFTR gene in 1989, research into gene-based therapies for the disease began. However, early trials did not show much success. Instead, they led to massive immunological issues. Despite this, researchers continued to pursue gene-based therapies.
Several companies have begun to work on gene-based therapies for CF. One company, Verona Pharma, is working on a drug that blocks two enzymes responsible for dilating the airways. The drug also helps to clear mucus membranes and reduce inflammation.
Another group is using messenger RNA to deliver the CFTR gene directly into the lungs. The drug has potential to work as a treatment for patients with splicing mutations.
One of the most challenging problems with gene-based therapy for CF is delivering the gene into the smallest parts of the lungs. Although liposome-based treatments have improved, it is still difficult to get a therapeutic effect in all patients.
The Cystic Fibrosis Foundation has announced six-year funding for research into gene-based treatments. In addition, the pharmaceutical firm Boehringer Ingelheim in Ingelheim, Germany, has signed a pre-clinical agreement with Oxford BioMedica to develop lentiviral gene therapy for cystic fibrosis.
Cystic Fibrosis – Do You Have Cystic Fibrosis?
CF is an inherited condition that affects about 30,000 people in the United States. The disease comes from mutations in the CFTR gene. Symptoms vary depending on the type of mutation. Those affected by cystic fibrosis may also have problems with the pancreas. These symptoms include thick mucus, chronic infections, and a decreased ability to absorb essential nutrients.
There are two types of genetic mutations that can cause cystic fibrosis: heterozygous and homozygous. Heterozygous mutations occur when two copies of the CFTR gene contain the same pathogenic variant. There are over 700 mutations identified in the CFTR gene, and the severity of the disease is often based partly on the type of defect.
The most common mutation is delta F508, which accounts for 70 percent of all mutations. Another common mutation is a deletion of the third DNA base.
Most labs test for about 30 to 100 total mutations. They are able to detect most of them. However, some mutations remain unnoticed.
The prognosis of a person with cystic fibrosis depends on the type of defect, how severe the disease is, and what treatment options are available. It is estimated that the average life expectancy of a patient with the disease is about 40 years. Children are usually diagnosed around age two. When a child is diagnosed early, treatment can be effective.
CF is a hereditary condition that affects the exocrine glands, such as the pancreas and lungs. The disease causes thick mucus to build up, preventing proper lung cleansing. The thick secretions can also contribute to the growth of bacteria and fungus.
Cystic fibrosis inheritance
CF is inherited through a genetic disorder called autosomal recessive inheritance. This means that a child must inherit two abnormal copies of the CFTR gene from both parents to get the disease.
People with cystic fibrosis have an abnormality in their genes that prevents the absorption of salt from sweat. This causes overheating and abnormal heart rhythms. In severe cases, patients may experience pain, nausea and vomiting.
People with CF are also at risk of developing liver and pancreas problems, including scarring of the liver. They may have abnormally low insulin levels, which can cause problems with growth and development. They also may develop osteoporosis due to a lack of vitamin D.
Although there is no cure for CF, improved treatments have helped people with the disease live longer. Children with CF are diagnosed through a genetic test. The diagnosis can help determine if they are eligible for a transplant for their lungs or their heart.
Symptoms of CF can vary widely, but in most cases, the first sign is meconium ileus, a thick, sticky substance made by the baby’s gut before birth. The stools are watery and bloated, and can be very painful.
Individuals with African and Asian ancestry are also at risk of developing cystic fibrosis. However, CF is more common among Caucasians. CF is inherited through the CFTR gene, which is found on the seventh chromosome. It makes a protein that controls the movement of salt and water in the body.
Cystic fibrosis inheritance pattern
CF is an autosomal recessive genetic disease. It is characterized by an abnormally thick mucus that clogs the pancreatic ducts and prevents the pancreas from working properly. This causes digestive problems and leads to respiratory insufficiency.
People with cystic fibrosis have two non-working copies of the CFTR gene. These mutations prevent the protein from functioning. The symptoms vary from person to person, and some people experience only mild respiratory problems.
The CFTR gene is located on the seventh chromosome. It is responsible for regulating the flow of salt and fluids in and out of cells. Without this protein, the body cannot balance the amounts of chloride and water in the body.
The CFTR gene is found in lungs, skin, pancreas, liver, and other tissues. The different proteins that it produces can cause different symptoms. A mutation in the CFTR can prevent the protein from working, resulting in a condition that affects the digestive system, reproductive tract, and respiratory tract.
The CFTR gene has over 700 mutations. The most common mutation is delta F508 which accounts for 70 percent of all cystic fibrosis cases. This mutation is more prevalent in people of northern European descent.
Having the mutated gene may leave some individuals undiagnosed. If you are concerned that you have a faulty CFTR gene, you can ask for testing. You can also contact your doctor for additional information. If you have a family history of CF or have a CF partner, you may be a carrier and you should get tested.
If you liked the article, please donate!